FDA's June 4 early alert says certain Omnipod pods may have small cannula tears that can leak insulin, under-deliver treatment, and in severe cases lead to diabetic ketoacidosis; Insulet reported 24 serious injuries and no deaths as of May 20. [1][2]

The scout memo identified a possible online-mainstream gap around insulet's pod warning is a diabetic ketoacidosis risk, not a gadget glitch, but no verified same-session status URL is attached; this article keeps that online frame unproved and anchors the public record in the cited record.

The reader test for insulet's pod warning is a diabetic ketoacidosis risk, not a gadget glitch is the public record: if a later source changes that record, the frame changes; if it only changes the argument around the record, the article should not pretend the evidence moved.

That makes FDA the starting point rather than the whole story, because a brief still owes readers the exact object to revisit when the next update arrives and a plain reminder that the most useful follow-up will change the record, not merely the volume of attention around it, especially when the public argument is moving faster than the source trail.

The empty X stack is a boundary: without a verified status URL for insulet's pod warning is a diabetic ketoacidosis risk, not a gadget glitch, the piece does not claim a social-media consensus.

-- NORA WHITFIELD, Chicago